A double-blind placebo-controlled pilot study of immunoglobulin for small fiber neuropathy associated with TS-HDS and FGFR-3 autoantibodies.
Christopher H GibbonsSharika RajanKatherine SenechalErin HendryBrady McCallisterTodd D LevinePublished in: Muscle & nerve (2022)
This pilot study did not detect a benefit of treatment with IVIG in patients with SFN and autoantibodies to TS-HDS and FGFR-3.